-
Signature
-
/s/ Stephen Dobson, as attorney-in-fact for Adam Elsesser
-
Stock symbol
-
PEN
-
Transactions as of
-
Jul 23, 2025
-
Transactions value $
-
-$2,926,294
-
Form type
-
4
-
Date filed
-
7/25/2025, 07:32 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Elsesser Adam |
CEO and President, Director |
ONE PENUMBRA PLACE, ALAMEDA |
/s/ Stephen Dobson, as attorney-in-fact for Adam Elsesser |
2025-07-25 |
0001651323 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PEN |
Common Stock |
Options Exercise |
$839K |
+28K |
+20.81% |
$30.00 |
162K |
Jul 23, 2025 |
Direct |
|
| transaction |
PEN |
Common Stock |
Sale |
-$842K |
-3.63K |
-2.23% |
$232.11 |
159K |
Jul 23, 2025 |
Direct |
F1, F2 |
| transaction |
PEN |
Common Stock |
Sale |
-$2.01M |
-8.62K |
-5.43% |
$233.29 |
150K |
Jul 23, 2025 |
Direct |
F1, F3 |
| transaction |
PEN |
Common Stock |
Sale |
-$912K |
-3.9K |
-2.6% |
$233.86 |
146K |
Jul 23, 2025 |
Direct |
F1, F4 |
| holding |
PEN |
Common Stock |
|
|
|
|
|
578K |
Jul 23, 2025 |
By Trust |
F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PEN |
Stock Option (right to buy) |
Options Exercise |
$0 |
-28K |
-25% |
$0.00 |
83.9K |
Jul 23, 2025 |
Common Stock |
28K |
$30.00 |
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: